US Patent 11667905 Cysteine protease
Patent 11667905 was granted and assigned to Hansa Biopharma on June, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 18 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 7 Jun, 2023
Golden AI
Edits made to:
Infobox (+11 properties)
Article (+290 characters)
US Patent 11667905 Cysteine protease
Article
The present invention relates to a novel polypeptide which displays IgG cysteine protease activity, and in vivo and ex vivo uses thereof. Uses of the polypeptide include methods for the prevention or treatment of diseases and conditions mediated by IgG, and methods for the analysis of IgG.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
116679050
Date of Patent
June 6, 2023
0Patent Application Number
176443150
Date Filed
December 14, 2021
0Patent Primary Examiner
Find more entities like US Patent 11667905 Cysteine protease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.